What is dialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Dialysis

Dialysis is a life-sustaining medical treatment that artificially removes accumulated metabolic waste products, excess fluid, and rebalances electrolytes in patients who have total or near-total loss of kidney function. 1

Core Mechanism

Dialysis works through two primary processes 1, 2:

  • Diffusion dialysis: Solutes move from blood into a physiological salt solution (dialysate) across a semipermeable membrane, driven by concentration gradients
  • Ultrafiltration: Excess body water is removed through pressure gradients across the dialyzer membrane 3, 2

The dialysate composition resembles plasma water, with electrolytes adjusted to compensate for abnormalities of end-stage renal disease 2.

Primary Dialysis Modalities

Hemodialysis (HD)

  • Blood is circulated outside the body through a dialyzer containing a semipermeable membrane 1
  • Typically performed 3 times weekly for 3-4 hours per session 1
  • Requires vascular access via arteriovenous fistula (preferred), arteriovenous graft, or central venous catheter 1
  • Can be performed in-center or at home 1

Peritoneal Dialysis (PD)

  • Uses the patient's peritoneal membrane as the dialyzing surface 1
  • Dialysate is instilled into the peritoneal cavity through a permanent catheter 1
  • Can be performed as continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) 1
  • Generally less efficient than hemodialysis for solute and fluid removal 1

Continuous Renal Replacement Therapies (CRRT)

  • Used primarily in critically ill, hemodynamically unstable patients 1
  • Includes continuous hemofiltration, hemodialysis, and hemodiafiltration 1
  • Provides better hemodynamic stability and fluid balance control compared to intermittent hemodialysis 1

Clinical Context and Indications

Dialysis is indicated when kidney failure causes 1:

  • Persistent hyperkalemia unresponsive to medical management
  • Severe metabolic acidosis
  • Volume overload unresponsive to diuretic therapy
  • Overt uremic symptoms including pericarditis, encephalopathy, nausea, and fatigue 3
  • Severe progressive hyperphosphatemia (>6 mg/dL) or symptomatic hypocalcemia 1

Timing of Initiation

The decision to initiate dialysis should be based on clinical symptoms and signs rather than estimated glomerular filtration rate (eGFR) alone. 1, 3

  • A randomized trial showed no mortality benefit to starting dialysis at higher eGFR (10-14 mL/min/1.73 m²) versus lower eGFR (5-7 mL/min/1.73 m²) 3
  • Initiation requires shared decision-making between patient and physician, considering uremic symptoms, nutritional status, and ability to manage metabolic abnormalities 1

Outcomes and Survival

  • More than 540,000 patients in the US receive maintenance dialysis 3
  • Five-year survival rate is approximately 40% after dialysis initiation 3
  • First-year mortality ranges from 17-20% depending on region and risk factors 4
  • Observational data show no significant mortality difference between hemodialysis and peritoneal dialysis 3

Common Pitfalls

Do not initiate dialysis based solely on eGFR thresholds without uremic symptoms present 5, as this leads to earlier treatment without survival benefit and increased resource utilization 1.

Recognize that dialysis is not appropriate for all patients 1—older patients with multiple comorbidities, frailty, or limited life expectancy may benefit more from comprehensive conservative care without dialysis 1.

Alternative to Dialysis

Comprehensive conservative care is a valid treatment option for advanced chronic kidney disease that includes active symptom management, shared decision-making, advance care planning, and psychosocial support—but does not include dialysis 1. This approach may be appropriate for patients unlikely to benefit from dialysis in terms of survival or quality of life 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hemodialysis. Basic principles and practice.

Postgraduate medicine, 1985

Guideline

Dialysbehandling för Patienter med Terminal Njursvikt

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Polycystic Kidney Disease and End-Stage Renal Disease Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the approach to managing tremors in a patient with end-stage renal disease (ESRD) undergoing peritoneal dialysis?
Is uremic breath a criterion for urgent dialysis (Dialysis)?
Does hemodialysis (hemodialysis, a treatment for Impaired renal function) increase the likelihood of hospitalization due to complications?
In patients with end‑stage renal disease (ESRD), what are the indications for initiating dialysis, the preferred dialysis modalities (hemodialysis (HD) versus peritoneal dialysis (PD)), treatment protocols, and management of common complications?
What is the approach to managing hyponatremia in patients with end-stage renal disease (ESRD) on peritoneal dialysis (PD) versus hemodialysis (HD)?
In a patient with compensated cirrhosis, blood pressure 116/64 mmHg, normal renal function, and no ascites or peripheral edema, should furosemide 20 mg plus spironolactone 50 mg and carvedilol (non‑selective beta‑blocker) be started?
In a 43-year-old patient with deep‑vein thrombosis and pulmonary embolism, what is the recommended approach to assess provocation, perform limited cancer screening, and implement age‑appropriate preventive health screening?
Should a patient with compensated cirrhosis, normal blood pressure (116/64 mm Hg), normal renal function and no ascites or edema start carvedilol and diuretics (furosemide 20 mg and spironolactone 50 mg daily)?
What diagnostic work‑up and initial management are recommended for a patient with livedo‑type skin changes, tissue tenderness, dry‑eye symptoms, and an isolated elevated C‑reactive protein despite normal complete blood count, coagulation profile, and basic metabolic panel?
What is the appropriate emergency department management for a patient presenting with acute anterior uveitis characterized by eye pain, photophobia, redness, decreased vision and anterior chamber cells/flare?
What oral elemental iron dose is appropriate for an adult with a hemoglobin of 8.9 g/dL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.